Titan Pharma jumps on funding from Bill & Melinda Gates Foundation

Titan Pharmaceuticals

25/10/2021 13:06

** Shares in specialty pharmaceutical co  TTNP.O  jump ~28%
to $2.24 premarket, set for their best day in nearly a year
    ** TTNP shares set to open at their highest level in more
than three months
    ** Co receives funding from the Bill & Melinda Gates
Foundation to develop combination HIV preventative therapeutic
and contraceptive implant for women in low- and middle-income
countries  urn:newsml:reuters.com:*:nPn6qWpBpa
    ** TTNP did not disclose the funding amount 
    ** TTNP down ~47% YTD, as of Friday close

 (Reporting by Deborah Sophia and Uday Sampath in Bengaluru)
 ((DeborahMary.Sophia@thomsonreuters.com;))